4Espina V, Dettloff KA, Cowherd S, et al. Use of proteomic analysis to monitor responses to biological therapies. Expert Opin Biol Ther,2004,4(1):83-93.
5Wulfkuhle JD, Aquino JA, Calver VS, et al. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics,2003,3(11):2085-2090.
6Friedrich MJ. Genomics and proteomics may help clinicians individualize cancer treatment.JAMA,2002,287(22):2931-2932.
7Reynolds T. For proteomics research, a new race has begun. J Natl Cancer Inst, 2002, 94(8):552-554.
8Pandey A. Proteomics to study genes and genomes. Nature, 2000,405(6788):837-846.
9Wu W, Hu W, Kavanagh JJ. Proteomics in cancer research. Int J Gynecol Cancer, 2002, 12(5):409-423.
10Issaq HJ, Veenstra TD, Conrads TP, et al. The SELDI-TOP MS approach to proteomics:protein profiling and biomarker identification.Biochem Biophys Res Commun,2002,292(3):587-592.
